Citation Tools

Download PDFPDF

178 Phase 2 trial of induction therapy with anti-CD20 (Rituximab) followed by maintenance therapy with anti-BAFF (Belimumab) in patients with active lupus nephritis
Free

Download to a citation manager

Cite this article as:
Aranow C, DallEra MC, Byron M, et al
178 Phase 2 trial of induction therapy with anti-CD20 (Rituximab) followed by maintenance therapy with anti-BAFF (Belimumab) in patients with active lupus nephritis